A while back, the British Medical Journal explored the idea of disease mongering and CME's potential place in it (i.e., Did GlaxoSmithKline “invent” irritable bowel syndrome in part by underwriting CME on the subject?). The idea must have been...
Here's an editorial by Jerome P. Kassirer from yesterday's Boston Globe that points to meetings specifically as being one of pharma's media of influence over physicians. He uses the recent $185 million class action lawsuit against Bristol-Myers...
Charles Willis, director, AMA PRA Standards, Division of Continuing Physician Professional Development with the ...
In case you're not sure how well-prepared healthcare workers feel when it comes to a possible avian flu pandemic, this survey of primary care physicians by Pri-Med Research should eliminate any doubts...
On Friday, Abbott Laboratories was suspended from the Association of the British Pharmaceutical Industry for at least six months for violating the ABPI Code of Practice. According to this article in the Financial Times, the company got in trouble...
Here's a nice roundup on the PhRMA Code (links to PDF download), from PhRMA. And the graphics are really nice, too.
(Thanks to Debra for the pointer!)
From a press release: ...
From the Washington Post: Cleveland Clinic to Tighten Its Disclosure Policies. It sounds like all the bad press the clinic received last year over ties its doctors had with companies that make the products and procedures it was testing prompted...